Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

The economic burden of diabetic retinopathy in Germany in 2002

Happich, Michael, Reitberger, Ursula, Breitscheidel, Lusine, Ulbig, Michael, Watkins, Jessamy · 2007 · Graefe's Archive for Clinical and Experimental Ophthalmology

Abstract

Background The aims of our study were to describe the costs associated with diabetic retinopathy (DR), and to evaluate its economic impact in Germany.Methods Forty-one German ophthalmologists, randomly selected from a physicians' database in Germany, provided information on adult Type 1 and Type 2 diabetic patients with DR (n = 207). This information included socio-demographics, clinical characteristics and resource use during the year 2002. National-level cost estimates were calculated, based on these results and the prevalence data on DR in Germany.Results This study found that costs associated with DR tend to increase as DR progresses, being highest in patients with proliferative DR and lowest in patients with mild, non-proliferative DR. The German statutory health insurance (Gesetzliche Krankenversicherung, GKV) covered two-thirds of the total costs paid by all the payers. The total cost of DR from a societal perspective was calculated at 3.51 euros bn for the year 2002, and from the GKV perspective amounted to 2.23 euros bn.Conclusions This study is the first comprehensive study to provide estimates of costs associated with DR in Germany. These costs were estimated to account for approximately 1.5% of the total health-care expenditure in 2002.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00417-007-0573-x

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 16 references

Research works printed but not linked: 2

  1. Hörle S, Kroll P (2005) Evidence based medicine using the example of diabetic retinopathy treatment. Dtsch Arztebl 102(38):2570–2577 (in German)
  2. Rote Liste Service GmbH (2002) Rote Liste 2002. Editio Cantor, Aulendorf

Cited by

See all 63

Metadata

Authors
Happich, M., Reitberger, U., Breitscheidel, L., Ulbig, M., & Watkins, J.
Affiliations
  • Eli Lilly (Germany) (DE)
  • Ludwig-Maximilians-Universität München (DE)
Corresponding author
Breitscheidel, Lusine
Venue
Graefe's Archive for Clinical and Experimental Ophthalmology
Published
2007-04-04
Volume
246
Issue
1
Pages
151-159
ISSN
  • 0721-832X (ISSN-L)
  • 1435-702X
OpenAlex
W2054763804
Cited by
63
References
16
Citations by year
2026: 2 · 2025: 1 · 2024: 8 · 2023: 9 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 2 · 2017: 3 · 2016: 2 · 2015: 2 · 2013: 2 · 2012: 3
FWCI
4.17
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Graefe s Archive for Clinical and Experimental Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Eli Lilly and Company
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
diabetic retinopathy, economic burden, health care costs, type 1 diabetes, type 2 diabetes, proliferative diabetic retinopathy, non-proliferative diabetic retinopathy, statutory health insurance, health care expenditure, Germany
MeSH terms
Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Health Expenditures, Female, Germany, Health Services Research, Health Status, Health Surveys, Humans, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Retrospective Studies, Databases, Factual, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The economic burden of diabetic retinopathy in Germany in 2002. https://app.cochat.ai/papers/10.1007/s00417-007-0573-x
The paper
Happich, M., Reitberger, U., Breitscheidel, L., Ulbig, M., & Watkins, J. (2007). The economic burden of diabetic retinopathy in Germany in 2002. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-007-0573-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.